|
|
US 7,482,459 B2 |
|
| [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an
inhibitor of mast cell tryptase |
| Zhongli Gao, Flemington, N.J. (US); Larry Davis, Sergeantsville, N.J. (US); Julian Levell, Arlington, Mass. (US); Mark Czekaj, Doylestown, N.J. (US); and Adam W. Sledeski, Belle Mead, N.J. (US) |
| Assigned to Aventis Pharmaceuticals Inc., Bridgewater, N.J. (US) |
| Filed on Sep. 14, 2006, as Appl. No. 11/520,998. |
| Application 11/520998 is a continuation of application No. PCT/US2005/009899, filed on Mar. 24, 2005. |
| Claims priority of provisional application 60/556927, filed on Mar. 26, 2004. |
| Prior Publication US 2007/0142435 A1, Jun. 21, 2007 |
| Int. Cl. C07D 211/00 (2006.01); C07D 409/00 (2006.01); C07D 405/00 (2006.01)
|
